Value proposition

Using Immunology to Fight Cancer; ImmunoBody® and Moditope® Cancer Vaccines; AvidiMab® and GlyMab® antibody platforms


Cancer remains one of the world's most significant diseases. A key challenge in the fight against cancer is that many tumours continue to grow by successfully evading the body's own natural defence mechanism - the immune system. Scancell's mission is to overcome this breach in our defences by developing products that stimulate the immune system to treat or prevent cancer.